Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.6.99.5 (NADH dehydrogenase)
 2,135 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Coenzyme Q is required in the electron transport system of rat hepatocyte and human erythrocyte plasma membranes. Extraction of coenzyme Q from the membrane decreases NADH dehydrogenase and NADH:oxygen oxidoreductase activity. Addition of coenzyme Q to the extracted membrane restores the activity. Partial restoration of activity is also found with alpha-tocopherylquinone, but not with vitamin K1. Analogs of coenzyme Q inhibit NADH dehydrogenase and oxidase activity and the inhibition is reversed by added coenzyme Q. Ferricyanide reduction by transmembrane electron transport from HeLa cells is inhibited by coenzyme Q analogs and restored with added coenzyme Q10. Reduction of external ferricyanide and diferric transferrin by HeLa cells is accompanied by proton release from the cells. Inhibition of the reduction by coenzyme Q analogs also inhibits the proton release, and coenzyme Q10 restores the proton release activity. Trans-plasma membrane electron transport stimulates growth of serum-deficient cells, and added coenzyme Q10 increases growth of HeLa (human adenocarcinoma) and BALB/3T3 (mouse fibroblast) cells. The evidence is consistent with a function for coenzyme Q in a trans-plasma membrane electron transport system which influences cell growth.
 ...
PMID:Requirement for coenzyme Q in plasma membrane electron transport. 145 89

The reductant dependence of iron mobilization from isolated rabbit reticulocyte endosomes containing diferric transferrin is reported. The kinetic effects of acidification by a H(+)-ATPase are eliminated by incubating the endosomes at pH 6.0 in the presence of 15 microM FCCP to acidify the intravesicular milieu and to dissociate 59Fe(III) from transferrin. In the absence of reductants, iron is not released from the vesicles, and iron leakage is negligible. The second-order dependence of rate constants and amounts of 59Fe mobilized from endosomes using ascorbate, ferrocyanide, or NADH are consistent with reversible mechanisms. The estimated apparent first-order rate constant for mobilization by ascorbate is (2.7 +/- 0.4) x 10(-3) s-1 in contrast to (3.2 +/- 0.1) x 10(-4) s-1 for NADH and (3.5 +/- 0.6) x 10(-4) s-1 for ferrocyanide. These results support models where multiple reactions are involved in complex processes leading to iron transfer and membrane translocation. A type II NADH dehydrogenase (diaphorase) is present on the endosome outer membrane. The kinetics of extravesicular ferricyanide reduction indicate a bimolecular-bimolecular steady-state mechanism with substrate inhibition. Ferricyanide inhibition of 59Fe mobilization is not detected. Significant differences between mobilization and ferricyanide reduction kinetics indicate that the diaphorase is not involved in 59Fe(III) reduction. Sequential additions of NADH followed by ascorbate or vice versa indicate a minimum of two sites of 59Fe(III) residence; one site available to reducing equivalents from ascorbate and a different site available to NADH. Sequential additions using ferrocyanide and the other reductants suggest interactions among sites available for reduction. Inhibition of ascorbate-mediated mobilization by DCCD and enhancement of ferrocyanide and NADH-mediated mobilization suggest a role for a moiety with characteristics of a proton pore similar to that of the H(+)-ATPase. These data provide significant constraints on models of iron reduction, translocation, and mobilization by endocytic vesicles.
 ...
PMID:Kinetic characterization of reductant dependent processes of iron mobilization from endocytic vesicles. 153 18

Transplasma membrane electron transport from HeLa cells, measured by reduction of ferricyanide or diferric transferrin in the presence of bathophenanthroline disulfonate, is inhibited by low concentrations of adriamycin and adriamycin conjugated to diferric transferrin. Inhibition with the conjugate is observed at one-tenth the concentration required for adriamycin inhibition. The inhibitory action of the conjugate appears to be at the plasma membrane since (a) the conjugate does not transfer adriamycin to the nucleus, (b) the inhibition is observed within three minutes of addition to cells, and (c) the inhibition is observed with NADH dehydrogenase and oxidase activities of isolated plasma membranes. Cytostatic effects of the compounds on HeLa cells show the same concentration dependence as for enzyme inhibition. The adriamycin-ferric transferrin conjugate provides a more effective tool for inhibition of the plasma membrane electron transport than is given by the free drug.
 ...
PMID:Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates. 156 98

The response of rainbow trout (Oncorhynchus mykiss, Walbaum) towards probiotics present in the feed was investigated by examining the proteome of serum as a measure of the acute phase response (APR). Proteomic analysis by two-dimensional electrophoresis (2D) concurrently with mass spectrometry was used to detect APR related proteins in rainbow trout serum following feeding with probiotics Aeromonas sobria GC2 and Bacillus sp. JB-1. Three candidate proteins increased following use of GC2, and were putatively identified as NADH dehydrogenase, dystrophin and mKIAA0350. Conversely, one of the proteins, which were induced following use of JB-1 was identified as transferrin.
 ...
PMID:Proteomic analysis of rainbow trout (Oncorhynchus mykiss, Walbaum) serum after administration of probiotics in diets. 1798 40

Iron belongs to the most widely distributed elements and is essential for the metabolism of almost all organisms. It is required for enzymatic reactions, in particular of those involving electron transport. It also participates in the transport and storage of oxygen in tissues. Iron is present in hem-containing proteins (hemoproteins) such as: hemoglobin, myoglobin, cytochromes,cytochrome oxidases, catalases and peroxidases. It is also a constituent of proteins which do not contain hem molecule: flavoproteins (succinate and NADH dehydrogenase) and of mitochondrial aconitase. In addition, iron takes part in many metabolic processes, among others in synthesis and catabolism of some hormones, synthesis of high-energy compounds and collagen, detoxification processes and immune reactions. It also participates in formation of reactive oxygen species which may exhibit both beneficial and harmful effects. Iron occurs in aqueous solutions as ferric (Fe+++) and ferrous (Fe++) ion. Although Fe+++ is hardly soluble, the organisms evolved mechanisms allowing to acquire and utilize that element irrespectively of its valency. The iron metabolism encompasses: intake, transport, participation in metabolism and storage. The iron metabolism undergoes in a closed cycle; in the physiological state only small amount of this metal is absorbed in the alimentary duct and disposed from the organism. A number of proteins is involved in iron metabolism including: ferritin, transferrin,transferrin receptor, divalent metal transporter (DMT1), cytochrome b, ferroportin, hephaestin, hepcidin and lactoferrin (LF). A beneficial effect of LF on iron acquisition in the gut is best documented.That process involves a receptor-mediated absorption of iron-bound LF through intestinal epithelial cells. The role of LF in transfer of iron from maternal milk may be of utmost importance. Many observations indicate also that LF participates in the process of iron storage,predominantly in the liver. Contradictory data exist, however, regarding the role of LF in iron transport to other cell types and organs.
 ...
PMID:[The role of lactoferrin in the iron metabolism. Part I. Effect of lactofferin on intake, transport and iron storage]. 1900 83